Supporting Accelerate to Zero: The BMGF Malaria Vector Control

Similar documents
BMGF MALARIA STRATEGY TO 2020

Strategy to move from accelerated burden reduction to malaria elimination in the GMS by 2030

Annex 2 A. Regional profile: West Africa

NO MORE MISSED MDG4 OPPORTUNITIES: OPTIMIZING EXISTING HEALTH PLATFORMS FOR CHILD SURVIVAL. Measles & Rubella Campaigns

WHO Consultation on universal access to core malaria interventions in high burden countries: main conclusions and recommendations

Prioritizing Emergency Polio Eradication Activities

WHO Global Task Force on TB Impact Measurement An overview

Fighting Harder and Smarter Against Malaria. Dr.Bernard Nahlen Deputy US Global Malaria Coordinator University of Georgia, February 23, 2010

Progress on the Containment of Artemisinin Tolerant Malaria Parasites in South-East Asia (ARCE) Initiative

MALARIA ELIMINATION AND ERADICATION: HOPES, CHALLENGES, BARRIERS

Ending Malaria in Nigeria: The WHO Agenda

WHO Global Malaria Programme. February 2009

Wild Poliovirus*, 03 Aug 2004 to 02 Aug 2005

Media centre Malaria. Key facts. Symptoms

Copenhagen, Denmark, September August Malaria

What is this document and who is it for?

Summary World Malaria Report 2010

Repellent Soap. The Jojoo Mosquito. Africa s innovative solution to Malaria prevention. Sapphire Trading Company Ltd

Renewing Momentum in the fight against HIV/AIDS

Evidence Review Group on MDA, MSAT and FSAT Malaria Policy Advisory Committee Geneva, Switzerland September 2015

Summary of the Eighth Meeting of the ITFDE (II) October 4, 2005

Roadmaps as a Vehicle for Addressing Large- Scale Public Health Challenges: Lessons from the Malaria Vaccine Technology Roadmap

Topical and spatial repellents: where are we?

Malaria DR. AFNAN YOUNIS

Analysis of the demand for a malaria vaccine: outcome of a consultative study in eight countries

My Fellowship Achievements

Global reductions in measles mortality and the risk of measles resurgence

Okinawa, Toyako, and Beyond: Progress on Health and Development

Launch of a supplement in Health Policy and Planning. Dr. Joy Lawn Mary Kinney Anne Pfitzer On behalf of the team

Revised Strategy for Malaria Control in the South-East Asia Region

The Challenge of Malaria

Report to the. GAVI Alliance Board November 2013

MALARIA SUMMIT COMMITMENTS

Universal Access to Reproductive Health: Strengthening Institutional Capacity. Why? What? And How?

U.S. Response to the Global Threat of Malaria: Basic Facts

POLIO ERADICATION IN THE AFRICAN REGION: PROGRESS REPORT. Information document EXECUTIVE SUMMARY

Disease Narrative for Malaria and Areas for Intervention

Addressing climate change driven health challenges in Africa

Aboubacar Kampo Chief of Health UNICEF Nigeria

Update from GAVI Aurelia Nguyen

ASEAN Declaration of Commitment on HIV and AIDS: Fast-Tracking and Sustaining HIV and AIDS Responses To End the AIDS Epidemic by 2030

Latest Funding Trends in AIDS Response

Global Overview Polio Partners Group, December Note: Gavi requirements of $122.2 million are not included in this slide

Mosquito-borne virus prevention and control: a global perspective

Maternal, Newborn and Child Health: Global initiatives and priority products for MNCH Dr. Mark W. Young Senior Health Specialist, UNICEF-New York

Mathematical modelling approach to estimating TB burden in children Pete Dodd (University of Sheffield) & James Seddon (Imperial College London)

EXECUTIVE SUMMARY THE PRESIDENT S MALARIA INITIATIVE

Accelerating Emergency Polio Eradication Activities. SAGE, November 6, 2012

Key Messages for World Malaria Day 2009

Investing for a Malaria-Free World

INVESTING FOR A MALARIA-FREE WORLD

PPFP Global Meeting Follow-up Workshop. Country Posters

Neglected Tropical Diseases

TB Disease Prevalence Survey - Progress Report

Elimination of VL in the Indian subcontinent is it achievable?

Accelerating US Progress in Combating Malaria Worldwide. Recommendations for Maximizing Investments Toward a World Free From Malaria

Ethiopia Malaria Financial Landscape

polio STRATEGY OVERVIEW

For information on programmes in other countries and regions please access the Federation website at Programme title 2005

Progress report on emerging and re-emerging diseases including dengue and dengue haemorrhagic fever

D.A.Henderson, MD, MPH. Professor of Medicine, University of Pittsburgh Honorary Fellow, London School of Hygiene and Tropical Medicine

26/06/ NIMR 2018 Conference - Malaria - a reality

Fact sheet. Poliomyelitis. WHO Media centre. ADAPTED FOR ADDITION TO THE RHIZOME POLIOK.IT PLATFORM 16 Jan 2017 INFORMATION FOR ERADICATION FROM

Malaria Elimination: Future Reality?

128th Session 25 November 2010 Provisional agenda item Malaria. Prevention and control: sustaining the gains and reducing transmission

Malaria Transmission Consortium. A multi-institution, 5-year malaria research project funded by the Bill & Melinda Gates Foundation

For more information about the final programme, speakers or the EHFG conference please contact us directly!

Tanzania s Progress in Combating Malaria: Achievement and Challenges

Pneumococcal Conjugate Vaccine: Current Supply & Demand Outlook. UNICEF Supply Division

Gavi s strategic framework 22 June 2016

From a one-size-fits-all to a tailored approach for malaria control

Recipients of development assistance for health

Factsheet about Chikungunya

Global Immunizations & UNICEF s Role Dr. Robin Nandy Principal Advisor & Chief of Immunizations UNICEF Headquarters

Oral Polio Vaccine Supply Outlook. UNICEF Supply Division

Background. Proposed to develop a framework for action. Address by Foreign Minister Koumura

Humanitarian Initiative to Prepare for a Pandemic Influenza Emergency (HIPPIE) Ron Waldman, MD Avian and Pandemic Influenza Unit USAID/Washington

Entomological Surveillance Planning Tool (ESPT) New Challenges, New Tools in Vector Control Workstream, RBM VCWG February 8, 2018 Mövenpick, Geneva

Global Report on Antimalarial Drug. and the Global Plan for Artemisinin Resistance Containment (GPARC)

54% WHO s emergency response to artemisinin resistance SHARP DECLINE IN MALARIA CASES AND DEATHS SEEN ACROSS THE GMS BULLETIN #5 SEPTEMBER 2016

Malaria. Dr. Salim Abdulla, Director Ifakara Health Institute, Dar-es-salaam, Tanzania

Why does Diarrhea matter? PREVENTING MORE THAN ONE MILLION UNNECESSARY DEATHS EVERY YEAR

Poliovirus : éradication pour les prochaines JNI?

Republic of Kenya MINISTRY OF PUBLIC HEALTH & SANITATION ESSENTIAL. Malaria. Action Guide FOR KENYAN FAMILIES

Malaria Situation and Plan for Elimination in China

GLOBAL STATISTICS FACT SHEET 2015

EPIDEMIOLOGICAL SURVEILLANCE REPORT Malaria in Greece, 2017, up to 17/08/2017

Progress in scaling up voluntary medical male circumcision for HIV prevention in East and Southern Africa

ASLM Anti-microbial Resistance in Africa and Global Health Security. 9TH INTEREST WORKSHOP May 2015 Harare

Poliomyelitis eradication in the WHO European Region

Leaving no one behind in Asia and the Pacific. Steven J. Kraus Director UNAIDS Regional Support Team, Asia and the Pacific 28 th January 2015

Experiences on Workforce Development in Other Regions

Dengue Conference, Mandurai, India, July What role should mathematical models & transgenic mosquitoes play in dengue control programs in India?

Ending the AIDS Epidemic in Adolescents

TB Disease Prevalence Survey - Overview, why and how

Target Product Profile: Point-of-Care Malaria Plasmodium falciparum Highly Sensitive Rapid Diagnostic Test

Development assistance for HIV/AIDS, tuberculosis and malaria by channel

Scaling-Up Excellence

THE SITUATION OF YELLOW FEVER IN THE AFRICAN REGION: THE PLAN TO END YF EPIDEMICS IN 2026

WHO VACCINE SUPPLY & QUALITY SUPPORT FOR NATIONAL IMMUNIZATION PROGRAMMES

Transcription:

Supporting Accelerate to Zero: The BMGF Malaria Vector Control Research Agenda NCAR-CDC Climate and Health Workshop Boulder CO 14 Jul 2015 Mike Reddy PhD MPH Dan Strickman MS PhD Malaria, (Prevent Transmission Initiative) Global Health Program

A 25+ year arc to achieve our ambitious eradication goal A world free of malaria in 5 yrs in 6-15 yrs in 15-25 yrs in 25+ yrs Stage set for adoption of global eradication agenda: New drug and vector interventions needed to accomplish Pf and Pv elimination available and approved for use Foundation Accelerate to Zero strategies are proven to achieve elimination Global community mobilized around a common eradication goal Delivery of current interventions with new strategies optimized Eradication effort gathering momentum: New vaccine and vector suppression interventions to complete elimination available and approved for use in some settings Global leadership, financing, and policies needed to advance eradication galvanized Evidence from technical and operational feasibility studies of delivery models incorporated into or used to inform approved delivery policies Eradication efforts rolled out everywhere: Proven tools & delivery models deployed at scale in all endemic countries Financing and policy in place for sustained deployment of eradication effort Any additional interventions needed in global last mile settings developed and deployed Eradication achieved: Global Pf and Pv prevalence reduced to 0 2013 Bill & Melinda Gates Foundation 2

A High Level Strategy to Eradicate Malaria 1) Detect the parasite 2) Eliminate the parasite from its reservoir 3) Prevent transmission of the parasite Assumptions: New tools (Dx, Rx, Vx, Ix) and operational guidance are needed No single tool or activity by itself is the solution- history tells us this! Effective coordination/integration of these activities will be required to eradicate malaria Elimination of malaria will proceed in a geographic progression; management of re-infestation crucial if eradication is to be achieved

The world has three potential future trajectories for malaria......in our strategy, we have chosen to 'Accelerate to Zero', which leads to three overarching goals for the period (2015-2020) 10 Global annual malaria parasite incidence Resurgence 8 6 4 1 2 Goals 1 Accelerate to Zero Now (new strategies using current tools) 2 Prepare for the Future (new strategies using new tools) 3 Sustain Progress (current strategies using current tools) 2 Bend the Curve Sustain progress 3 0 2010 2015 2020 2025 2030 2035 2040 and beyond Accelerate to zero 2013 Bill & Melinda Gates Foundation 4

2015-2020 VECTOR CONTROL PRIORITIES Four priorities for action based on adequacy of available interventions in different prevent transmission scenarios, adequacy of vector control management for elimination, and known knowledge gaps Accelerate to Zero Now Prepare for the Future Sustain Gains 1. Product Development and Supply Prevent Transmission situation requires an intervention that we do not currently have Vector Control team will develop, help license and help commercialize a new product meeting the Prevent Transmission situation TPP 2. Operational Guidance Operational practice for a Prevent Transmission situation is not fit-for-purpose Vector Control team will identify best practice and work with Eliminate and Mobilize to enable adoption by WHO and other partners of needed operational guidance 3. Intelligence Gaps Intervention and operational practices needs for Prevent Transmission situation are unknown or uncertain Vector Control team will fill intelligence gaps through funding of targeted research work 4. Ready to Impact Needed interventions and fit-for-purpose operational practices are available for Prevent Transmission situation Vector Control team will work with Eliminate Initiative team to implement now in target geographies 2015 Bill & Melinda Gates Foundation 6

CURRENT SITUATION ASSESSMENT VS. PRIORITIES A significant number of countries are at Ready to Impact. However, many 2020 goal countries have product development, operational guidance or intelligence gaps 1. Product Development Gap Thailand, Gambia, Bangladesh 2. Operational Guidance Gap Bolivia, Angola, Zambia, Ethiopia, Afghanistan 1.,2. Product Development and Operational Guidance Gaps Sub-Saharan & West Africa, Cambodia, PNG, Pakistan 3. Intelligence Gap Nigeria, Niger, Sudan, South Sudan, Somalia, Lao PDR, Myanmar 4. Ready to Impact Western Pacific, India, South Africa, Saudi Arabia, Central and South America Not Malaria endemic 2015 Bill & Melinda Gates Foundation

Product Development and Supply PROPOSED APPROACH TO VECTOR SUPPRESSION Interventions can prevent vector contact, suppress vector populations and reduce vector transmission capacity to improve the technical and operational feasibility of elimination efforts and sustain gains through eradication A. Improve Technical Feasibility B. Improve Operational Feasibility C. Sustain Donor/ Country Affordability 1 Prevent Contact Between Humans and Malaria Vectors e.g. spatial repellents that protect all the occupants of a home e.g. apply user-centric design to empower the individual e.g. develop evidence base to make policy that allows donor support 2 Suppress Vector Populations e.g. new insecticide active ingredients to combat insecticide resistance e.g.manage use of new insecticides to avoid creation of resistance e.g.make integrated vector management part of intervention package to target more expensive products 3 Reduce the Capacity of Vectors to Transmit Malaria Parasites to Humans e.g. reduce vector populations through environmental management e.g. apply best practices to construction and road building e.g. include best practices in integrated vector management plans 2015 Bill & Melinda Gates Foundation

Reduction in Transmission After Intervention (Cumulative Impact) Product Development and Supply REQUIREMENT ANALYSIS Impact of Seasonality Key to Intervention Availability: We will bring to market vector control tools and invest in product development for new interventions to meet remaining gaps in the most challenging epidemiological situations Now Planned Residual Transmission Gap A Indoor Gap Spatial Repellents Eave Tubes LLINs, IRS Seasonal Transmission + New AI B Outdoor Gap ATSBs, Push-Pull, Autodissemination LLIHNs + New AI ORS, LSM, Fogging C Indoor Gap Spatial Repellents Eave Tubes Perennial Transmission D Outdoor Gap E Unknown Scenarios Particularly Challenging Vector Control Spatial Repellents Impact of Seasonality on Transmission Impact of Seasonality on Transmission LLINs, IRS + New AI ATSBs Push-Pull LLIHNs + New AI Topical Repellents, Treated clothing, Fogging LSM Least Challenging Increasing Transmission Challenge Most Challenging To be determined Source: Vector Control Sub-initiative strategy development, November 2014-March 2015 2014 Bill & Melinda Gates Foundation

PRODUCT DEVELOPMENT NEEDS ANALYSIS (in progress) 2015 Bill & Melinda Gates Foundation 10

EVIDENCE-BASED VECTOR SUPPRESSION Entomological and Environmental Monitoring Activities: - Vector identification/abundance measures - Pathogen and insecticide resistance detection - Correlates: environmental variables; allows for ecological niche modelling - Climate data First Step: Know thy enemy - Identification - Distribution - Behavior - Bionomics - Epidemiology Ensures continuous, successful integrated management Suppression measures taken to prevent pathogen transmission by a vector - Source reduction (environmental management/engineering) - Biological control (Bti, larvivorous fish, copepods) - Chemical control (LLINs, IRS, ULV sprays, repellents) - Genetic control (HEGs, RIDL, other GM approaches)

http://gcgh.grandchallenges.org/

THANK YOU! Dr. Mary Hayden National Center for Atmospheric Research Fellow workshop participants